Rein Therapeutics (RNTX)

Profile

Full Name

Rein Therapeutics Inc.

Ticker Symbol

RNTX

Exchange

NASDAQ

Country

United States

IPO

June 29, 2017

Indexes

Not included

Employees

11

Key Details

Price

$1.70(+3.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.51(-2.63% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

  • What is the ticker symbol for Rein Therapeutics?
  • Does Rein Therapeutics pay dividends?
  • What sector is Rein Therapeutics in?
  • What industry is Rein Therapeutics in?
  • What country is Rein Therapeutics based in?
  • When did Rein Therapeutics go public?
  • Is Rein Therapeutics in the S&P 500?
  • Is Rein Therapeutics in the NASDAQ 100?
  • Is Rein Therapeutics in the Dow Jones?
  • When was Rein Therapeutics's last earnings report?
  • When does Rein Therapeutics report earnings?
  • Should I buy Rein Therapeutics stock now?

What is the ticker symbol for Rein Therapeutics?

The ticker symbol for Rein Therapeutics is NASDAQ:RNTX

Does Rein Therapeutics pay dividends?

No, Rein Therapeutics does not pay dividends

What sector is Rein Therapeutics in?

Rein Therapeutics is in the Healthcare sector

What industry is Rein Therapeutics in?

Rein Therapeutics is in the Biotechnology industry

What country is Rein Therapeutics based in?

Rein Therapeutics is headquartered in United States

When did Rein Therapeutics go public?

Rein Therapeutics's initial public offering (IPO) was on June 29, 2017

Is Rein Therapeutics in the S&P 500?

No, Rein Therapeutics is not included in the S&P 500 index

Is Rein Therapeutics in the NASDAQ 100?

No, Rein Therapeutics is not included in the NASDAQ 100 index

Is Rein Therapeutics in the Dow Jones?

No, Rein Therapeutics is not included in the Dow Jones index

When was Rein Therapeutics's last earnings report?

Rein Therapeutics's most recent earnings report was on Apr 15, 2025

When does Rein Therapeutics report earnings?

The date for Rein Therapeutics's next earnings report has not been announced yet

Should I buy Rein Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page